QUIKPAC II ONE STEP COCAINE TEST— 510(k) K972059

Name: FDA 510(k) clearance K972059
Creator: U.S. Food and Drug Administration
Published: 1997-08-28

Substantially Equivalent

Drial Consultants, Inc.

FDA 510(k) clearance K972059 for QUIKPAC II ONE STEP COCAINE TEST, Substantially Equivalent on 1997-08-28. Applicant: Drial Consultants, Inc.. Device class: 2.

Clearance details

Applicant: Drial Consultants, Inc.
Product code: Product code DIO
Device class: Class 2
Regulation: 21 CFR 862.3250
Advisory panel: Clinical Toxicology
Date received: 1997-06-02
Decision date: 1997-08-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Simi Valley, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DIO

view all

K213211 — Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System2022-01-27
K211973 — DRI Cocaine Metabolite Assay2021-09-24
K191638 — Pointe Scientific Cocaine Metabolite Enzyme Immunoassay2020-03-12
K181499 — DRI Cocaine Metabolite Assay2018-07-06
K170293 — Emit II Plus Cocaine Metabolite Assay2017-10-25

More clearances from Drial Consultants, Inc.

view all

K973269 — QUIKSTRIP ONE STEP BENZODIAZEPINE TEST1998-02-25
K973326 — QUIKPAC II ONE STEP BENZODIAZEPINE TEST1998-02-24
K973047 — ONE STEP URINE DRUG OF ABUSE BARBITURATE TEST1997-10-02
K972571 — QUIKSTRIP ONE STEP OPIATES TEST1997-08-20
K972405 — QUIKPAC II ONE STEP OPIATE TEST1997-08-08

Data sourced from openFDA. This site is unofficial and independent of the FDA.